Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-23T10:42:23.573Z Has data issue: false hasContentIssue false

d-Fenfluramine and cognitive therapy in bulimia nervosa

Published online by Cambridge University Press:  02 January 2018

Sing Lee
Affiliation:
11/F, Prince of Wales' Hospital, Shatin, Hong Kong
Kathy Chan
Affiliation:
11/F, Prince of Wales' Hospital, Shatin, Hong Kong
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © Royal College of Psychiatrists, 1993 

References

Agras, W. S., Rossiter, E. M., Arnow, B., et al (1992) Pharmacologic and cognitive-behavioural treatment for bulimia nervosa: a controlled comparison. American Journal of Psychiatry, 149, 8287.Google Scholar
Fairburn, C. & Cooper, P. (1989) Eating disorders. In Cognitive Behaviour Therapy for Psychiatric Problems (eds Hawton, K., Salkovskis, P. M., Kirk, J. & Clark, M. C.), pp. 277314. New York: Oxford University Press.CrossRefGoogle Scholar
Fluoxetine Bulimia Nervosa Collaborative Study Group (1992) Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Archives of General Psychiatry, 49, 139147.CrossRefGoogle Scholar
Spitzer, R. L., Stunkard, A., Yanovski, S., et al (1993) Bingeeating disorder should be included in DSM-IV: a reply to Fairbum et al's “The Classification of recurrent Overheating: The Binge Eating Disorder Proposal”. International Journal of Eating Disorders, 13, 161169.3.0.CO;2-R>CrossRefGoogle Scholar
Wurtman, J. J., Wurtman, R. J. & Marks, S. (1985) d-Fenfluramine selectively suppresses carbohydrate snacking by obese subjects. International Journal of Eating Disorders, 4, 8999.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.